script by du (2013) Search Results


edoxaban  (Daiichi Sankyo)
90
Daiichi Sankyo edoxaban
Cost inputs
Edoxaban, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edoxaban/product/Daiichi Sankyo
Average 90 stars, based on 1 article reviews
edoxaban - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
script by du (2013)  (MathWorks Inc)
90
MathWorks Inc script by du (2013)
Cost inputs
Script By Du (2013), supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/script by du (2013)/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
script by du (2013) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
chemistryopen  (Verlag GmbH)
90
Verlag GmbH chemistryopen
Cost inputs
Chemistryopen, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemistryopen/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
chemistryopen - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pathologe  (Verlag GmbH)
90
Verlag GmbH pathologe
Cost inputs
Pathologe, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pathologe/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
pathologe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ricerca finalizzata 2013  (Olon Ricerca Bioscience)
90
Olon Ricerca Bioscience ricerca finalizzata 2013
Cost inputs
Ricerca Finalizzata 2013, supplied by Olon Ricerca Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ricerca finalizzata 2013/product/Olon Ricerca Bioscience
Average 90 stars, based on 1 article reviews
ricerca finalizzata 2013 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wiley-vch verlag  (Verlag GmbH)
90
Verlag GmbH wiley-vch verlag
Cost inputs
Wiley Vch Verlag, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wiley-vch verlag/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
wiley-vch verlag - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
morning pef  (Kamada)
90
Kamada morning pef
Cost inputs
Morning Pef, supplied by Kamada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/morning pef/product/Kamada
Average 90 stars, based on 1 article reviews
morning pef - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
stata/ic 13.1  (STATA Corporation)
90
STATA Corporation stata/ic 13.1
Cost inputs
Stata/Ic 13.1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stata/ic 13.1/product/STATA Corporation
Average 90 stars, based on 1 article reviews
stata/ic 13.1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
presto!  (ANSYS inc)
90
ANSYS inc presto!
Cost inputs
Presto!, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/presto!/product/ANSYS inc
Average 90 stars, based on 1 article reviews
presto! - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wiley-vch verlag gmadv  (Verlag GmbH)
90
Verlag GmbH wiley-vch verlag gmadv
Cost inputs
Wiley Vch Verlag Gmadv, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wiley-vch verlag gmadv/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
wiley-vch verlag gmadv - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wiley-vch verlag gadv  (Verlag GmbH)
90
Verlag GmbH wiley-vch verlag gadv
Cost inputs
Wiley Vch Verlag Gadv, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wiley-vch verlag gadv/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
wiley-vch verlag gadv - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
longitudinal—data/ panel—data reference manual release 13  (STATA Corporation)
90
STATA Corporation longitudinal—data/ panel—data reference manual release 13
Cost inputs
Longitudinal—Data/ Panel—Data Reference Manual Release 13, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/longitudinal—data/ panel—data reference manual release 13/product/STATA Corporation
Average 90 stars, based on 1 article reviews
longitudinal—data/ panel—data reference manual release 13 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Cost inputs

Journal: ClinicoEconomics and Outcomes Research: CEOR

Article Title: Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

doi: 10.2147/CEOR.S98888

Figure Lengend Snippet: Cost inputs

Article Snippet: The rationale for this was supported by the data from the pivotal trials of edoxaban (Daiichi Sankyo, data on file, 2013) and rivaroxaban, which showed that their relative efficacy versus warfarin did not differ by CHADS 2 score, so there was no need to stratify the thrombotic event risks by CHADS 2 score ( ).

Techniques:

Analysis results

Journal: ClinicoEconomics and Outcomes Research: CEOR

Article Title: Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

doi: 10.2147/CEOR.S98888

Figure Lengend Snippet: Analysis results

Article Snippet: The rationale for this was supported by the data from the pivotal trials of edoxaban (Daiichi Sankyo, data on file, 2013) and rivaroxaban, which showed that their relative efficacy versus warfarin did not differ by CHADS 2 score, so there was no need to stratify the thrombotic event risks by CHADS 2 score ( ).

Techniques:

Results of one-way sensitivity analyses

Journal: ClinicoEconomics and Outcomes Research: CEOR

Article Title: Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

doi: 10.2147/CEOR.S98888

Figure Lengend Snippet: Results of one-way sensitivity analyses

Article Snippet: The rationale for this was supported by the data from the pivotal trials of edoxaban (Daiichi Sankyo, data on file, 2013) and rivaroxaban, which showed that their relative efficacy versus warfarin did not differ by CHADS 2 score, so there was no need to stratify the thrombotic event risks by CHADS 2 score ( ).

Techniques: